Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2010 · fourth_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $55,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Consumer Issues/Safety/Products
Issues related to ticketing legislation H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $55,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $55,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Consumer Issues/Safety/Products
Regulations of tickets in the secondary market; H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795, Ticket Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to the use of behavioral tracking data to follow online activity; General issues related to comprehensive privacy legislation; Issue - Online Privacy, Data Security, and Identity Theft: S. 139, Data Breach Notification Act; H.R. 2221, Data Accountability and Trust Act S. 1490, Personal Data Privacy and Trust Act of 2009 HR 5777, BEST PRACTICES Act of 2010 S. 3742, Data Security and Breach Notification Act General issues related to protecting the ability of retailers to sell over the Internet; General issues related to the lawful and safe resale of events tickets: H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795 Tickets Act
Client expense: $397,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Postal Rate Commission, SENATE, U.S. Trade Representative (USTR), White House Office
2010 · fourth_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
2010 · third_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $65,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Consumer Issues/Safety/Products
Issues related to ticketing legislation H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $65,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to the use of behavioral tracking data to follow online activity; General issues related to comprehensive privacy legislation; Issue - Online Privacy, Data Security, and Identity Theft: S. 139, Data Breach Notification Act; H.R. 2221, Data Accountability and Trust Act S. 1490, Personal Data Privacy and Trust Act of 2009 HR 5777, BEST PRACTICES Act of 2010 S. 3742, Data Security and Breach Notification Act General issues related to protecting the ability of retailers to sell over the Internet; General issues related to the lawful and safe resale of events tickets: H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795 Tickets Act Issue - Retail Price Maintenance: S. 148/H.R. 3190, Discount Pricing Consumer Protection Act of 2009
Client expense: $411,450 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Postal Regulatory Commission, SENATE, Small Business Administration (SBA), U.S. Trade Representative (USTR), White House Office
2010 · third_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
2010 · third_quarter · Consumer Issues/Safety/Products
Regulations of tickets in the secondary market; H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795, Ticket Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Consumer Issues/Safety/Products
Regulations of tickets in the secondary market; H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795, Ticket Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to the use of behavioral tracking data to follow online activity; General issues related to comprehensive privacy legislation; Issue - Online Privacy, Data Security, and Identity Theft: S. 139, Data Breach Notification Act; H.R. 2221, Data Accountability and Trust Act S. 1490, Personal Data Privacy and Trust Act of 2009 General issues related to protecting the ability of retailers to sell over the Internet; General issues related to the lawful and safe resale of events tickets: H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795 Tickets Act Issue - Retail Price Maintenance: S. 148/H.R. 3190, Discount Pricing Consumer Protection Act of 2009
Client expense: $363,500 · Firm income: Not reported
2010 · second_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Consumer Issues/Safety/Products
Issues related to ticketing legislation H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Consumer Issues/Safety/Products
Regulations of tickets in the secondary market; H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795, Ticket Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
2010 · first_quarter · Arts/Entertainment
Performance Rights Act, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act H.R. 4353, Wireless Microphone Users Interference Protection Act
Client expense: Not reported · Firm income: Not reported
2010 · first_quarter · Communications/Broadcasting/Radio/TV
Performance Rights Act, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act H.R. 4353, Wireless Microphone Users Interference Protection Act
Client expense: Not reported · Firm income: Not reported
2010 · first_quarter · Consumer Issues/Safety/Products
Performance Rights Act, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act H.R. 4353, Wireless Microphone Users Interference Protection Act
Client expense: Not reported · Firm income: Not reported
2010 · first_quarter · Copyright/Patent/Trademark
Performance Rights Act, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act H.R. 4353, Wireless Microphone Users Interference Protection Act
Client expense: Not reported · Firm income: Not reported
2010 · first_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $90,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Consumer Issues/Safety/Products
Issues related to ticketing legislation H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $90,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Consumer Issues/Safety/Products
Issues related to ticketing legislation H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $90,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Arts/Entertainment
Performance Rights Legislation, S. 379/H.R. 848 H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009 H.R. 4795, The Ticket Act
Client expense: $90,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
General issues related to the use of behavioral tracking data to follow online activity; General issues related to comprehensive privacy legislation; Issue - Online Privacy, Data Security, and Identity Theft: S. 139, Data Breach Notification Act; H.R. 2221, Data Accountability and Trust Act S. 1490, Personal Data Privacy and Trust Act of 2009 General issues related to protecting the ability of retailers to sell over the Internet; General issues related to the lawful and safe resale of events tickets: H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795 Tickets Act Issue - Retail Price Maintenance: S. 148/H.R. 3190, Discount Pricing Consumer Protection Act of 2009
Client expense: $539,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Small Business Administration (SBA), U.S. Trade Representative (USTR), White House Office
2010 · first_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
2010 · first_quarter · Consumer Issues/Safety/Products
Regulations of tickets in the secondary market; H.R. 2669, Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2009; H.R. 4795, Ticket Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
2009 · third_quarter · Tariff (miscellaneous tariff bills)
Duty suspension regarding the following: 1) Product: Difenoconazole, House Bill: HR 4794; 2) Product: DCDNBTF Benzene, House Bill: HR 4803; 3) Product: 2-Chloro-6- Fluorobenzyl, House Bill: HR 4805; 4)Product: Flumetralin Technical, House BIll: HR 4802; 5) Cyprodinil Tech, House Bill: HR 4793; 6) Product: Trinexapac-Ethyl Tech, House Bill: HR 4801; 7) Product: Lamda-Cyhalothrin, House Bill: HR 4797; 8) Product: Thia-Difen-Flud-Mef, House Bill: HR 4796; 9) Product: Difenoconazole & Mefenoxem, House Bill: HR 4795; 10) Product: Mucochloric Acid, House Bill: HR 4798; 11) Methidathion Tech, House Bill: HR 4800; 12) 4-Chloro-3.5 Dinitrobenzotrifluoride, House Bill: HR 4804; 13) Wakil XL, House Bill: HR 4799; 14) Thiamethoxam Tech, House Bill: HR 4728; 15) Trifloxysulfuron-Sodium Tech, House Bill: HR 4730; 16) Triasulfuron Tech, House Bill: HR 4729; 17) Propiconazole Tech; 18) Paraquat Dechloride Tech, House Bill: HR 4642; 19) NOA 446510 Tech, House Bill: HR 4639; 20) IPN, House Bill: HR 4640; 21) Paclobutrazol 2SC, House Bill: HR 4643; 22) Paclobutrazol Tech, House Bill: HR 4638; 23) Brodifacoum Tech, House Bill: HR 4644; 24) Azoxystrobin Technical-benzeneacertic; 25) Fludioxinil Tech, House Bill: HR 4711; 26) Clodinafop Tech; House Bill: HR 4712; 27) Pinoxaden Tech; House Bill: HR 4715; 28) Azoxystrobin Technical; House Bill: HR 4792; 29) Mefenoxam Tech; House Bill: HR 4714; 30) TEHP; 31) Cloquintocet Tech; House BIll: HR 4709; 32) Prosulfuron Tech; House Bill: HR 4717; 33) Avermectin B; House Bill: HR 4708; 34) Cyproconazole Tech, House Bill: HR 4710; 35) Pymetrozine Tech, House Bill: HR 4718; 36) Primisulfuron; 37) Mesotrione Tech, House Bill: HR 4366; 38) s-Metolachlor; 39) DEMBB -Bromo, House Bill: HR 4365; 40) Promdiamine Tech, House Bill: HR 4572; 41) Chloroacetone, House Bill: HR 4641; 42) Ortho-Nitro-Phenol 2-Nitrophenol, House Bill: HR 4573.
Client expense: $230,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Small Business Administration (SBA), U.S. Trade Representative (USTR), White House Office
Client expense: $110,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
Client expense: $230,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
Client expense: $270,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Client expense: $210,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)